These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 513069)

  • 21. The cytotoxicity of symmetrical and unsymmetrical bis(thiosemicarbazones) and their metal complexes in murine and human tumor cells.
    Hall IH; Lackey CB; Kistler TD; Ives JS; Beraldo H; Ackerman LJ; West DX
    Arch Pharm (Weinheim); 2000 Jul; 333(7):217-25. PubMed ID: 10965596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of N-heterocyclic carboxaldehyde thiosemicarbazone derivatives.
    Iigo M; Hoshi A; Kuretani K; Natsume M
    Gan; 1977 Apr; 68(2):221-5. PubMed ID: 892296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Adv Enzyme Regul; 1995; 35():55-68. PubMed ID: 7572354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EPR characterization of mono(thiosemicarbazones) copper(II) complexes. Note II.
    Pogni R; Baratto MC; Diaz A; Basosi R
    J Inorg Biochem; 2000 Apr; 79(1-4):333-7. PubMed ID: 10830885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal and antitumor activity of heterocyclic thiosemicarbazones and their metal complexes: current status.
    Liberta AE; West DX
    Biometals; 1992; 5(2):121-6. PubMed ID: 1525478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives.
    Ertas M; Sahin Z; Bulbul EF; Bender C; Biltekin SN; Berk B; Yurttas L; Nalbur AM; Celik H; Demirayak Ş
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900033. PubMed ID: 31475759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity.
    Yu Y; Suryo Rahmanto Y; Hawkins CL; Richardson DR
    Mol Pharmacol; 2011 Jun; 79(6):921-31. PubMed ID: 21389104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function correlations in the reaction of bis(thiosemicarbazonato) copper(II) complexes with Ehrlich ascites tumor cells.
    Minkel DT; Saryan LA; Petering DH
    Cancer Res; 1978 Jan; 38(1):124-9. PubMed ID: 563285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytotoxicity of heterocyclic thiosemicarbazones and their metal complexes on human and murine tissue culture cells.
    Hall IH; Rajendran KG; West DX; Liberta AE
    Anticancer Drugs; 1993 Apr; 4(2):231-40. PubMed ID: 8490202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
    Cory JG; Fleischer AE
    Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaction of copper complexes with Ehrlich cells.
    Petering DH
    Adv Exp Med Biol; 1977; 91():179-91. PubMed ID: 75680
    [No Abstract]   [Full Text] [Related]  

  • 33. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
    Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
    Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure-activity relationships among alpha-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1-specified ribonucleoside diphosphate reductase.
    Turk SR; Shipman C; Drach JC
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1625-32. PubMed ID: 3016157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and Metal Ion Effects on Human Topoisomerase IIα Inhibition by α-(N)-Heterocyclic Thiosemicarbazones.
    Morris WH; Ngo L; Wilson JT; Medawala W; Brown AR; Conner JD; Fabunmi F; Cashman DJ; Lisic EC; Yu T; Deweese JE; Jiang X
    Chem Res Toxicol; 2019 Jan; 32(1):90-99. PubMed ID: 30484632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of the Impact of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα.
    Wilson JT; Jiang X; McGill BC; Lisic EC; Deweese JE
    Chem Res Toxicol; 2016 Apr; 29(4):649-58. PubMed ID: 26982206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
    Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
    Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative analysis of steric and hydrophobic effects in ribonucleoside diphosphate reductase inhibition by thiosemicarbazones.
    Gupta SP; Prabhakar YS; Bindal MC; Handa A
    Arzneimittelforschung; 1984; 34(2):147-50. PubMed ID: 6372802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.